Published in Int J Nucl Med Biol on March 01, 1978
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases. Br Med J (Clin Res Ed) (1984) 1.14
High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur J Clin Nutr (2004) 1.06
Professional football (soccer) players have a markedly greater skeletal mineral content, density and size than age- and BMI-matched controls. Calcif Tissue Int (1998) 1.02
Risk for developing osteoporosis in untreated premature menopause. Calcif Tissue Int (1992) 1.01
Pseudohypoparathyroidism 1942-1966. A negative progress report. Am J Med (1967) 0.98
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
Circadian rhythm of urinary total and free hydroxyproline excretion and its relation to creatinine excretion. J Lab Clin Med (1970) 0.94
Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH). Bone Miner (1991) 0.94
Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia. J Clin Densitom (2001) 0.86
Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD). Bone Miner (1992) 0.86
Seasonal variations of 25 hydroxyvitamin D and parathyroid hormone in Ushuaia (Argentina), the southernmost city of the world. Bone Miner (1993) 0.85
Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporos Int (1991) 0.85
The treatment of Paget's bone disease with sodium ethidronate. Am J Med Sci (1979) 0.84
Intestinal absorption of phosphate: action of protein synthesis inhibitors and glucocorticoids in the rat. J Nutr (1976) 0.83
Tertiary hyperparathyroidism diagnosed after renal homotransplantation. Am J Med (1970) 0.81
Parathyroid hormone and vertebral osteosclerosis in uremic patients. Metabolism (1976) 0.81
Hyperthyroidism influences ultrasound bone measurement on the Os calcis. Osteoporos Int (1998) 0.81
Efficacy of the bisphosphonate APD in the control of Paget's bone disease. Bone (1985) 0.81
Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment. Acta Endocrinol (Copenh) (1991) 0.80
Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas (1994) 0.80
Letter: Circadian rhythm of the total hydroxyproline: creatinine ratio in urine. Clin Sci Mol Med (1974) 0.80
[Winter serum levels of 25-hydroxy-vitamin D in Ushuaia and Buenos Aires]. Medicina (B Aires) (1990) 0.79
European origin of patients with Paget's disease of bone in the Buenos Aires area. Eur J Epidemiol (2001) 0.79
Vertebral compression fractures at the onset of acute lymphoblastic leukemia in a child. Henry Ford Hosp Med J (1991) 0.78
Estimating body fat and lean tissue distribution in hyperthyroidism by dual-energy X-ray absorptiometry. J Clin Densitom (2002) 0.78
Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3. Am J Med Sci (1979) 0.78
Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease. Lancet (1975) 0.78
Intestinal absorption of calcium in fasting patients. Lancet (1970) 0.78
Iodide-peroxidase activity in human thyroid. I. Studies on non-toxic nodular goitre. Acta Endocrinol (Copenh) (1969) 0.77
[Serum levels of 25-hydroxyvitamin D in the normal population of Buenos Aires: its seasonal variation]. Medicina (B Aires) (1987) 0.77
[Nutritional status of vitamin D in mothers and neonates of Ushuaia and Buenos Aires]. Medicina (B Aires) (1993) 0.77
Effects of Solanum malacoxylon on calcium metabolism in patients with chronic renal failure. Calcif Tissue Res (1977) 0.76
Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr (2006) 0.76
Mechanism of action of solanum malacoxylon upon calcium and phosphate metabolism in the rabbit. Endocrinology (1972) 0.76
Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma. Medicina (B Aires) (1991) 0.76
Iodine-131 whole-body scan for post-surgical follow-up of differentiated thyroid carcinoma. J Nucl Med (1991) 0.75
[Use of the 8th day test in patients with high values of thyroid radioiodine uptake in 24 hours]. Rev Argent Endocrinol Metab (1968) 0.75
[Solanum malacoxylon: comparison of its biological activity after oral or parenteral administration to laboratory animals]. Medicina (B Aires) (1974) 0.75
Profile scanning with 47Ca and 32P in skeletal disease--a preliminary comparison. Int J Nucl Med Biol (1980) 0.75
Hypercalcaemia in pregnancy in a renal transplant recipient with secondary hyperparathyroidism. Case report. Br J Obstet Gynaecol (1990) 0.75
[Serum values and thyroid hormones exchange in the aged]. Medicina (B Aires) (1979) 0.75
Ultrasound parameters and markers of bone turnover in hyperthyroidism: a longitudinal study. J Clin Densitom (2004) 0.75
[Study of the thyroid function in patients with lingual thyroid]. Rev Clin Esp (1966) 0.75
[Kinetics of iodine and endemic goiter]. Rev Argent Endocrinol Metab (1969) 0.75
[The Solanum molacoxylon: from the toxic plant to the therapeutic agent (author's transl)]. Nouv Presse Med (1978) 0.75
Calcitonin is a competitive inhibitor of the hydrosmotic effect of oxytocin in toad bladder. Am J Physiol (1988) 0.75
Effect of Solanum malocoxylon on the serum levels of calcium and phosphate in thyroparathyroidectomized and rachitic rats. Calcif Tissue Res (1973) 0.75
[Epidemiology of proximal femoral fractures in La Plata, Argentina]. Medicina (B Aires) (1991) 0.75
[Heredity in the prevalence of arterial hypertension. Its relation to plasma renin activity and noradrenaline excretion]. Medicina (B Aires) (1980) 0.75
[Decrease in the bone mineral content in patients on maintenance hemodialysis]. Medicina (B Aires) (1987) 0.75
[Intestinal absorption of 32P in hypoparathyroid patients. Effect of vitamin D2 therapy]. Medicina (B Aires) (1980) 0.75
Effect of parathyroid hormone on bone resorption in uremic patients. Medicina (B Aires) (1976) 0.75
The intestinal absorption of phosphate in normal human subjects. Adv Exp Med Biol (1977) 0.75
Treatment of Paget's bone disease with a bisphosphonate. Medicina (B Aires) (1984) 0.75
[Undifferentiated large cell carcinoma of the thyroid. Anatomo-clinical study of 21 cases]. Medicina (B Aires) (1979) 0.75
[Bone mineral density in osteoporotic and normal women of Buenos Aires]. Medicina (B Aires) (1993) 0.75
[Surgical treatment of hyperparathyroidism]. Medicina (B Aires) (1972) 0.75
Failure of oral calcium to enhance the acute antiosteolytic effect of calcitonin. Calcif Tissue Int (1987) 0.75
Compensatory parathyroid hypertrophy after hemiparathyroidectomy in rats feeding a low calcium diet. Calcif Tissue Int (1991) 0.75
[Study of post-total thyroidectomy thyroid remnants by scintillography (112 cases)]. Rev Clin Esp (1973) 0.75
[Endemic goiter in a Mapuche population of Chiquillihuin, Province of Nueguén. 3. Kinetic studies]. Rev Argent Endocrinol Metab (1969) 0.75
[Use of iodized salt. Effect on iodine metabolism in a zone not considered endemic of goiter]. Medicina (B Aires) (1973) 0.75
Short-term therapy with oral olpadronate in active Paget's disease of bone. J Bone Miner Res (1999) 0.75
Healing of osteitis fibrosa cystica after partial parathyroidectomy despite persistent parathyroid hyperfunction: a case report. Metab Bone Dis Relat Res (1982) 0.75
[Osteoporosis in all young daughters of a mother with multiple osteoporotic fractures. A case of familial osteoporosis]. Medicina (B Aires) (2001) 0.75
Determination of the optimum window for whole body counting of 47Ca. Int J Nucl Med Biol (1974) 0.75
Effect of hydrochlorothiazide upon serum and urinary calcium in patients with hypoparathyroidism. Medicina (B Aires) (1975) 0.75
[Study of thyroid function with radioactive isotopes]. Rev Argent Endocrinol Metab (1968) 0.75
[Influence of sex and age on the blood calcium of blood donors]. Medicina (B Aires) (1973) 0.75
Parathyroid activity and bone formation. Metabolism (1976) 0.75
[Endemic goiter in a Mapuche population of Chiquillihin, Province of Neuquen. I. Incidence of goiter and characteristics of the population studies]. Rev Argent Endocrinol Metab (1968) 0.75
Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats. Inflammation (1988) 0.75
Biologic studies on the relationship between thyroid stimulating and ophthalmotrophic activities. Acta Physiol Lat Am (1967) 0.75
Antiarthritic synergism of combined oral and parenteral chrysotherapy. II. Increased inhibition of activated leukocyte oxygen burst by combined gold action. Inflammation (1988) 0.75
[Endemic goiter in a Mapuche population of Chiquillihuín, Province of Neuquén. V. Thyroid release of nonhormonal iodine]. Rev Argent Endocrinol Metab (1969) 0.75
[Use of adrenergic beta blockaders in thyrotoxicosis and hypothyroidism]. Prensa Med Argent (1970) 0.75
[Proximal femoral fractures: risk factors, bone mineral density, body composition and biochemical changes in and age-matched patients and controls]. Medicina (B Aires) (1996) 0.75
Calcium kinetics in the Solanum malacoxylon-treated rat. J Nutr (1975) 0.75
[Endemic goiter in a Mapuche population of Chiquillihuín, Province of Neuguén. II. Characteristics of iodine metabolism]. Rev Argent Endocrinol Metab (1969) 0.75
Biochemical studies on the iodine organification defect of Pendred's syndrome. Acta Endocrinol (Copenh) (1978) 0.75
[Hypothalamo-hypophyseal-thyroid axis in the aged]. Medicina (B Aires) (1978) 0.75
The intestinal absorption of phosphate in normal human subjects. Int J Nucl Med Biol (1979) 0.75
[Plasmatic clearance of iodine in thyroid diseases]. Rev Argent Endocrinol Metab (1966) 0.75
Treatment of Paget's bone disease with the bisphosphonate APD. Henry Ford Hosp Med J (1983) 0.75
Metabolic behaviour of human growth hormone. J Nucl Biol Med (1973) 0.75
Measurement of human growth hormone production rate. Recommendations for a standardized protocol. Int J Nucl Med Biol (1976) 0.75
Thyroid tumour scanning with 197HgCl2. Preliminary note. Nucl Med (Stuttg) (1970) 0.75
[Metabolic effects of Solanum malacoxylon in thyroparathyroidectomized rats]. Medicina (B Aires) (1979) 0.75
[Tritiated water in the determination of total body water by means of the use of a liquid scintillation counter. Normal values and variations according to body weight modifications]. Rev Argent Endocrinol Metab (1965) 0.75
Calcium metabolism in patients with acute renal failure. Medicina (B Aires) (1975) 0.75